• A
  • A
  • A
  • ABC
  • ABC
  • ABC
  • А
  • А
  • А
  • А
  • А
Regular version of the site

News

Illustration for news: Members of the International Laboratory of Microphysiological Systems Took Part in SIBS-2021

Members of the International Laboratory of Microphysiological Systems Took Part in SIBS-2021

The 5th Sechenov International Biomedical Summit (SIBS - 2021) was held on November 9-10, 2021 at FSAU VO Sechenov Russian Ministry of Health (Sechenov University). It is one of the most authoritative forums in the country in the field of advanced bioengineering, regenerative and personalized medicine.

Illustration for news: Members of the International Laboratory of Microphysiological Systems and the Laboratory of Molecular Physiology participated in RECOMB 2021

Members of the International Laboratory of Microphysiological Systems and the Laboratory of Molecular Physiology participated in RECOMB 2021

25th International Conference on Research in Computational Molecular Biology (RECOMB 2021) was held online on August 29th - September 2nd. Staff of the Faculty of Biology and Biotechnology - Stepan Nersisyan, Alexey Galatenko, Diana Maltseva and Alexander Tonevitsky participated in a poster session with the report 'miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence'

Illustration for news: The International Laboratory of Microphysiological Systems at the 11th World Congress on Alternatives and Uses of Animals in Natural Sciences (WC11)

The International Laboratory of Microphysiological Systems at the 11th World Congress on Alternatives and Uses of Animals in Natural Sciences (WC11)

Alexander G. Tonevitsky, Leading Research Fellow of the International Laboratory of Microphysiological Systems, took part at the 11th World Congress on Alternatives and Use of Animals in Natural Sciences (WC11)

Frontiers Pharmacology magazine published an article «HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons»

A collaborative study by a group of scientists from the International Laboratory for Microphysiological Systems has been published that analyzes the potential benefits and challenges of using HIF prolyl hydroxylase inhibitors as a treatment for COVID-19


12